Cardiovascular Risk in HIV/AIDS and Lipodystrophy Syndrome Patients

  • Valdelias Xavier Pereira
  • Fernando Rocha Oliveira
  • Luiz Carlos de Abreu Faculdade de Medicina do ABC. Departamento de Saúde da Coletividade. Disciplina de Metodologia Científica.
  • Mariliza Henrique da Silva
  • Celso Ferreira Filho
  • Fernando Adami
  • Francisco Winter do Santos Figueiredo
  • Laércio da Silva Paiva
  • Renata Macedo Martins Pimentel
  • Vitor Engracia Valenti
  • Adriano Luis Roque
  • Rubens Wajnsztejn
  • Tatiana Dias de Carvalho
  • Karina Viviani de Oliveira Pessoa
  • Celso Ferreira

Abstract

Background:The treatment of people living with AIDS, known a highly active antiretroviral therapy (HAART), has increased considerably, and the disease has therefore acquired chronic features. Several changes have been observed, especially in cardiovascular disease risk. Objective: To assess cardiovascular risk in HIV/AIDS patients treated with HAART and compare this with Lipodystrophy Syndrome (LS) carriers. Methods: This is a descriptive cross-sectional study. 192 patients were recruited from a lipodystrophy outpatient centre, using Framingham risk scores. Results: After criteria inclusion/exclusion, the final sample consisted of 81 patients divided into two groups (HIV/AIDS - without lipodystrophy and HIV/LS - with lipodystrophy). The mean age of HIV/AIDS was 46.5 years, and of the HIV/LS patients was 52 years. In accordance with Framingham scores the cardiovascular risk in HIV/AIDS was 46.59% and 14.29% in HIV/LS. Conclusion: The risk of cardiovascular disease over 10 years is significantly higher in patients with lipodystrophy syndrome.

Published
Oct 6, 2015
How to Cite
PEREIRA, Valdelias Xavier et al. Cardiovascular Risk in HIV/AIDS and Lipodystrophy Syndrome Patients. International Archives of Medicine, [S.l.], v. 8, oct. 2015. ISSN 1755-7682. Available at: <http://imed.pub/ojs/index.php/iam/article/view/1278>. Date accessed: 22 oct. 2018. doi: http://dx.doi.org/10.3823/1813.
Section
Cardiovascular Biology

Keywords

HIV, AIDS, cardiovascular disease, highly active antiretroviral therapy

Most read articles by the same author(s)

1 2 3 > >>